Vonvendi Approved to Control Bleeding Disorder

TUESDAY, Dec. 8, 2015 — Vonvendi has been approved to treat adults with von Willebrand disease (VWD), the most common inherited bleeding disorder.
VWD, affecting about 1 percent of the U.S. population, is caused by lack of a protein that’s…
Source: Topamax